Boston, MA -- (SBWIRE) -- 01/29/2014 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: HEMP, INC. (OTCMKTS:HEMP), Konared Corp (OTCBB:KRED), Cannabis Science Inc (OTCMKTS:CBIS), Advanced Cell Technology, Inc. (OTCMKTS:ACTC)
HEMP, INC. (OTCMKTS:HEMP) decreased -11.25% at the price of $0.0710 recently on a traded volume of 37.90 million shares, in comparison to 56.46 million shares of average trading volume. So far this year, the stock is up over 254.77%.
The company has a total market capitalization of $18.23 million. Hemp, Inc. focuses on supplying services, products, and information related to the medical marijuana industry or to those who have an affinity for the medical marijuana industry.
Has HEMP Found The Bottom and Ready To Move Up? Find Out Here
Konared Corp (OTCBB:KRED) plunged -4.33% at the trading price of $0.995 on a traded volume of 3.07 million shares till now, whereas its average trading volume is 1.04 million shares. In the last three months, the stock is up 50%. The Intra-day range for the stock is $0.59 and $1.36. KonaRed Corporation., formerly TeamUpSport Inc. is a development-stage company. The Company is focused to develop and commercialize on its Website www.teamupsport.com. As of May 31, 2011, the Company had not generated revenue.
Has KRED Found The Bottom And Ready To Gain Momentum? Find Out Here
Cannabis Science Inc (OTCMKTS:CBIS) dropped down -20.31% at the $0.157 recently. So far in three months, the stock is up 291.2%. The 52-week range for the stock is $0.03 and $0.26. Its introductory price for the day was $0.20, with the overall traded volume of 28.87 million shares. Cannabis Science, Inc. is a development-stage company. Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.
Why Should Investors Buy CBIS After the Recent Fall? Just Go Here and Find Out
Advanced Cell Technology, Inc. (OTCMKTS:ACTC) after opening its shares at the price of $0.09, dropped -5.71% , its recent trading price was $0.0825 for the day. The stock moved on a traded volume of 22.36 million shares, in comparison to 11.99 million shares of average trading volume.
The 52-week range for the stock is $0.05 and $0.10. Its introductory price for the day was $0.09. Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the emerging field of regenerative medicine. The Company has acquired, developed and maintained a portfolio of patents and patent applications that forms the base for its research and development efforts in the area of embryonic and adult stem cell research.
Will ACTC Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)